Sébastien Duboeuf

  • Citations Per Year
Learn More
OBJECTIVES Some alloantibodies and their combinations can lead to delays or even an impasse in a transfusion, owing to the necessity of finding compatible red blood cell concentrates. The aim of this study was to determine the specificities of the most common alloantibodies, as well as the most common combinations of alloantibodies. METHODS AND MATERIALS(More)
Anti-erythrocyte alloimmunization may occur following the transfusion of platelet concentrates, in response to the presence of residual erythrocytes. Immunization against RH1 (D) antigen is the most frequent, but transfusion of RH1 compatible platelet concentrates is not always possible because of supply constraints. We report here three cases of anti-RH1(More)
Errors on identity of patients during their registration may lead to non-compliance with a transfusion procedure, a non-issue adjusted blood and thus a transfusion risk. The main mistake is the misknowledge of an antibody, secondarily a loss of transfusion information and a redundancy of examinations. The creation of a working group "identitovigilance"(More)
Screening of alloantibodies is required before each transfusion. As part of our blood bank quality assurance, we have developed a quality indicator to monitor these false positive antibody results. We have studied 25.162 samples: sera were first screened by automated column agglutination technology (CAT). Positive results were found in 1.365 of the 25.162(More)
  • 1